Am J Psychiatry 160:522-532, March 2003
© 2003 American Psychiatric Association
Differential Brain Metabolic Predictors of Response to Paroxetine in Obsessive-Compulsive Disorder Versus Major Depression
Sanjaya Saxena, M.D.,
Arthur L. Brody, M.D.,
Matthew L. Ho, B.S.,
Narineh Zohrabi, B.S.,
Karron M. Maidment, R.N., M.A., and
Lewis R. Baxter, Jr., M.D.
OBJECTIVE: Serotonin reuptake inhibitor (SRI) medications are effective in the treatment of both major depressive disorder and obsessive-compulsive disorder (OCD), but it is unknown whether the neural substrates of treatment response for the two disorders are the same or different. The authors sought to identify pretreatment cerebral glucose metabolic markers of responsiveness to SRI treatment in patients with OCD versus major depressive disorder and to determine whether the pretreatment patterns associated with improvement of OCD symptoms were the same as or different from those associated with improvement of major depressive disorder symptoms. METHOD: [18F]Fluorodeoxyglucose positron emission tomography was used to measure cerebral glucose metabolism in 27 patients with OCD alone, 27 with major depressive disorder alone, and 17 with concurrent OCD and major depressive disorder, who were all then treated with 30–60 mg/day of paroxetine for 8–12 weeks. Correlations were calculated between pretreatment regional metabolism and pre- to posttreatment changes in the severity of OCD symptoms, depressive symptoms, and overall functioning. RESULTS: While improvement of OCD symptoms was significantly correlated with higher pretreatment glucose metabolism in the right caudate nucleus (partial r=–0.53), improvement of major depressive disorder symptoms was significantly correlated with lower pretreatment metabolism in the amygdala (partial r=0.71) and thalamus (partial r=0.34) and with higher pretreatment metabolism in the medial prefrontal cortex and rostral anterior cingulate gyrus (Talairach coordinates: x=0, y=62, z=10) (z=2.91). CONCLUSIONS: These findings suggest that, although both OCD and major depressive disorder respond to SRIs, the two syndromes have different neurobiological substrates for response. Elevated activity in the right caudate may be a marker of responsiveness to antiobsessional treatment, while lower right amygdala activity and higher midline prefrontal activity may be required for response of depressive symptoms to treatment.
This article has been cited by other articles:
|
|
|
|
 
B. J. Harrison, C. Soriano-Mas, J. Pujol, H. Ortiz, M. Lopez-Sola, R. Hernandez-Ribas, J. Deus, P. Alonso, M. Yucel, C. Pantelis, et al.
Altered Corticostriatal Functional Connectivity in Obsessive-compulsive Disorder
Arch Gen Psychiatry,
November 1, 2009;
66(11):
1189 - 1200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Machado-Vieira, H. K. Manji, and C. A. Zarate
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
Neuroscientist,
October 1, 2009;
15(5):
525 - 539.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. H. Kennedy, J. Z. Konarski, Z. V. Segal, M. A. Lau, P. J. Bieling, R. S. McIntyre, and H. S. Mayberg
Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial
Am J Psychiatry,
May 1, 2007;
164(5):
778 - 788.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Y. Joe, T. Tielmann, J. Bucerius, M. J. Reinhardt, H. Palmedo, W. Maier, H.-J. Biersack, and A. Zobel
Response-Dependent Differences in Regional Cerebral Blood Flow Changes with Citalopram in Treatment of Major Depression
J. Nucl. Med.,
August 1, 2006;
47(8):
1319 - 1325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Van Laere, B. Nuttin, L. Gabriels, P. Dupont, S. Rasmussen, B. D. Greenberg, and P. Cosyns
Metabolic Imaging of Anterior Capsular Stimulation in Refractory Obsessive-Compulsive Disorder: A Key Role for the Subgenual Anterior Cingulate and Ventral Striatum
J. Nucl. Med.,
May 1, 2006;
47(5):
740 - 747.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. P. Taylor, G. E. Bruder, J. W. Stewart, P. J. McGrath, J. Halperin, H. Ehrlichman, and F. M. Quitkin
Psychomotor Slowing as a Predictor of Fluoxetine Nonresponse in Depressed Outpatients
Am J Psychiatry,
January 1, 2006;
163(1):
73 - 78.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Fineberg, T. M. Gale, and T. Sivakumaran
A review of antipsychotics in the treatment of obsessive compulsive disorder
J Psychopharmacol,
January 1, 2006;
20(1):
97 - 103.
[PDF]
|
|
|
|
|
|
|
A. Etkin, C. Pittenger, H. J. Polan, and E. R. Kandel
Toward a Neurobiology of Psychotherapy: Basic Science and Clinical Applications
J Neuropsychiatry Clin Neurosci,
May 1, 2005;
17(2):
145 - 158.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Neumeister, A. C. Nugent, T. Waldeck, M. Geraci, M. Schwarz, O. Bonne, E. E. Bain, D. A. Luckenbaugh, P. Herscovitch, D. S. Charney, et al.
Neural and Behavioral Responses to Tryptophan Depletion in Unmedicated Patients With Remitted Major Depressive Disorder and Controls
Arch Gen Psychiatry,
August 1, 2004;
61(8):
765 - 773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Saxena, A. L. Brody, K. M. Maidment, E. C. Smith, N. Zohrabi, E. Katz, S. K. Baker, and L. R. Baxter Jr.
Cerebral Glucose Metabolism in Obsessive-Compulsive Hoarding
Am J Psychiatry,
June 1, 2004;
161(6):
1038 - 1048.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Mataix-Cols, S. Wooderson, N. Lawrence, M. J. Brammer, A. Speckens, and M. L. Phillips
Distinct Neural Correlates of Washing, Checking, and Hoarding Symptom Dimensions in Obsessive-compulsive Disorder
Arch Gen Psychiatry,
June 1, 2004;
61(6):
564 - 576.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
